1. Home
  2. FSLY vs VCYT Comparison

FSLY vs VCYT Comparison

Compare FSLY & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastly Inc.

FSLY

Fastly Inc.

N/A

Current Price

$23.19

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Logo Veracyte Inc.

VCYT

Veracyte Inc.

N/A

Current Price

$41.12

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSLY
VCYT
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
FSLY
VCYT
Price
$23.19
$41.12
Analyst Decision
Hold
Strong Buy
Analyst Count
8
7
Target Price
$18.00
$44.00
AVG Volume (30 Days)
4.8M
1.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
27.19
164.52
EPS
N/A
0.66
Revenue
$624,018,000.00
N/A
Revenue This Year
$16.39
$13.76
Revenue Next Year
$10.73
$12.35
P/E Ratio
N/A
$61.92
Revenue Growth
14.78
N/A
52 Week Low
$7.74
$29.46
52 Week High
$34.82
$60.91

Technical Indicators

Market Signals
Indicator
FSLY
VCYT
Relative Strength Index (RSI) 49.53 39.93
Support Level $22.72 $40.80
Resistance Level $25.36 $42.98
Average True Range (ATR) 1.44 1.76
MACD -0.07 0.14
Stochastic Oscillator 54.73 11.02

Price Performance

Historical Comparison
FSLY
VCYT

About FSLY Fastly Inc.

Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: